Global trial progress has built on Lind’s method, now incorporating placebos, double-blinding, and adherence to ethical standards like the Nuremberg Code and Good Clinical Practice.

Clinical Trials Day commemorates the 1747 first randomized trial by Dr. James Lind and honors patients, caregivers, researchers, and the broader research community.

May 20 is Clinical Trials Day, marking Lind’s scurvy trial aboard HMS Salisbury and the birth of the modern randomized controlled trial framework and evidence-based medicine.

ACRP’s 2026 Research Rising campaign aligns federal outreach with grassroots, state and local advocacy to raise visibility and support for the clinical research workforce.

The proclamations highlight the vital role of clinical research professionals in driving medical innovation and improving patient outcomes, spanning scientists, coordinators, nurses, patient advocates, and regulatory experts.

ACRP aims to expand proclamations in coming years to strengthen awareness, support the workforce, inspire future talent, and accelerate translation of discoveries into patient cures.

The day honors the legacy of Lind’s landmark trial and recognizes the contributions of clinical research professionals, patients, caregivers, and researchers.

A Clinical Trials Day 2026 site features more information and a gallery of proclamations, with opportunities for supporters to get involved.

Additional resources and involvement details are available through the proclamation gallery and related materials.

Overall, Clinical Trials Day is presented as both a historic homage and a practical strategy to validate and bolster the clinical research workforce while acknowledging ongoing challenges.

The timing underscores a workforce crisis in clinical research, including high turnover and staffing shortages that threaten trial timelines, with reports of impact on up to 95% of cancer centers.

Officials emphasize that the recognition is meaningful beyond symbolism, signaling ongoing efforts to elevate the profile of those advancing science and access to trials.